- PSTV Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-Q/A Filing
Plus Therapeutics (PSTV) 10-Q/A2013 Q3 Quarterly report (amended)
Filed: 12 Feb 14, 12:00am
Exhibit 31.1
Certification of Principal Executive Officer Pursuant to
Securities Exchange Act Rule 13a-14(a),
as Adopted Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
I, Christopher J. Calhoun, certify that:
1. | I have reviewed this quarterly report on Form 10-Q/A of Cytori Therapeutics, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: February 12, 2014 |
/s/ Christopher J. Calhoun |
Christopher J. Calhoun |
Chief Executive Officer |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.